Immune thrombocytopenia (ITP) is an autoimmune disorder characterised by both antibody-mediated platelet destruction and impaired megakaryocyte function. This results in decreased platelet counts and ...

Sanofi’s oral reversible Bruton’s tyrosine kinase (BTK) inhibitor, Wayrilz (rilzabrutinib), has secured approval from the US Food and Drug Administration (FDA) for adult patients with persistent or ...

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a Phase ...

Novartis said its ianalumab drug combined with eltrombopag met the primary endpoint in a late-stage trial, demonstrating a significant improvement in time to treatment failure for patients with ...

Sanofi SNY announced that the FDA has approved Wayrilz (rilzabrutinib), a novel BTK inhibitor, for the treatment of persistent or chronic immune thrombocytopenia (ITP) in adult patients who have had ...

Prednisone suppresses your immune system and can be used to treat conditions like blood cell disorders, arthritis, and skin ...

— NDA is supported by data from successful Phase III ESLIM-01 trial in patients with adult primary immune thrombocytopenia who have received at least one previous therapy — The NMPA granted ...

The National Institute for Health and Care Excellence (NICE) has issued draft final guidance in England and Wales recommending the use of avatrombopag (Doptelet, Sobi) in adults with primary chronic ...

Please provide your email address to receive an email when new articles are posted on . Rilzabrutinib induced rapid and durable clinical activity in previously treated patients with immune ...

Pivotal data from the first phase 3 study of a BTKi in immune thrombocytopenia (ITP) underscore the potential of rilzabrutinib to provide a clinically meaningful benefit to patients living with ITP ...

DelveInsight's,“ Immune Thrombocytopenia Pipeline Insight 2025 ” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Immune Thrombocytopenia pipeline landscape. It ...